TECAN LIMITED
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Fabricated Structural Metal, Miscellaneous Structural Metal Work, Fabricated Metal Products, Not Elsewhere Classified, Manufacturing Industries, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about TECAN LIMITED
Live alerts from global media, monitored by Business Radar
2024-09-30 (biomedcentral.com)
A metal-organic nanoframework for efficient colorectal cancer immunotherapy by the cGAS-STING pathway activation and immune checkpoint blockade - Journal of Nanobiotechnology
Immunotherapy has shown marked progress in promoting systemic anti-colorectal cancer (CRC) clinical effects. For further effectively sensitizing CRC to immunotherapy, we have engineered a pH-sensitive zeolitic imidazolate framework-8( CS/NPs), capable of efficient cGAS-STING pathway activation and
Read more
2024-06-28 (selectscience.net)
Tecan expands presence in the US with new distribution agreement for detection instruments
This collaboration will allow Tecan to expand its presence for these product lines and reach a wider customer base across the academic and biotech communities
Read more
2024-06-28 (selectscience.net)
Tecan expands presence in the US with new distribution agreement for detection instruments
This collaboration will allow Tecan to expand its presence for these product lines and reach a wider customer base across the academic and biotech communities
Read more
2023-04-11 (marketscreener.com)
Tecan : DYNEX Technologies and Tecan Partnership Expands Availability of ELISA Immunoassays in the U.S. | MarketScreener
April 11, 2023|Customer News DYNEX Technologies and Tecan Partnership Expands Availability of ELISA Immunoassays in the U.S. ... | April 11, 2023
Read more
2023-04-11 (marketscreener.com)
Tecan : DYNEX Technologies and Tecan Partnership Expands Availability of ELISA Immunoassays in the U.S. | MarketScreener
April 11, 2023|Customer News DYNEX Technologies and Tecan Partnership Expands Availability of ELISA Immunoassays in the U.S. ... | April 11, 2023
Read more
2020-08-21 (pharmiweb.com)
Tecan expands presence in the United States with new distribution agreement for detection instruments and consumables
Tecan is excited to announce an agreement with Thomas Scientific, a distributor of laboratory solutions and equipment, to support the sales of Tecan’s detection instruments and consumables portfolio in the US.
Read more
2020-08-21 (pharmiweb.com)
Tecan expands presence in the United States with new distribution agreement for detection instruments and consumables
Tecan is excited to announce an agreement with Thomas Scientific, a distributor of laboratory solutions and equipment, to support the sales of Tecan’s detection instruments and consumables portfolio in the US.
Read more
2020-07-03 (nature.com)
Butyrate producing colonic Clostridiales metabolise human milk oligosaccharides and cross feed on mucin via conserved pathways Communications
The early life human gut microbiota exerts life-long health effects on the host, but the mechanisms underpinning its assembly remain elusive. Particularly, the early colonization of Clostridiales from the Roseburia-Eubacterium group, associated with protection from colorectal cancer, immune- and metabolic disorders is enigmatic. Here, we describe catabolic pathways that support the growth of Roseburia and Eubacterium members on distinct human milk oligosaccharides (HMOs). The HMO pathways, which include enzymes with a previously unknown structural fold and specificity, were upregulated together with additional glycan-utilization loci during growth on selected HMOs and in co-cultures with Akkermansia muciniphila on mucin, suggesting an additional role in enabling cross-feeding and access to mucin O-glycans. Analyses of 4599 Roseburia genomes underscored the preponderance and diversity of the HMO utilization loci within the genus.
Read more